PILA — Pila Pharma AB Income Statement
0.000.00%
Last trade - 00:00- SEK71.16m
- SEK70.08m
- SEK0.77m
Annual income statement for Pila Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.719 | 1.88 | 1.46 | 0.775 |
| Cost of Revenue | |||||
| Gross Profit | -0.492 | 0.681 | 1.88 | -1.87 | -5.91 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.98 | 17.9 | 28.7 | 11.4 | 12 |
| Operating Profit | -6.98 | -17.2 | -26.8 | -9.89 | -11.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.98 | -17.2 | -26.8 | -9.93 | -11.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.98 | -17.2 | -26.8 | -9.93 | -11.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.98 | -17.2 | -26.8 | -9.93 | -11.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.98 | -17.2 | -26.8 | -9.93 | -11.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.183 | -0.636 | -0.46 | -0.272 | -0.286 |
| Dividends per Share |